Current status of the use of salvaged blood in metastatic spine tumour surgery

Neurospine

Volumn 15, Issue 3, 2018, Pages 206-215

  Kumar, Naresh ^a   Ravikumar, Nivetha ^a   Tan, Joel Yong Hao ^a   Akbary, Kutbuddin ^a   Patel, Ravish Shammi ^a   Kannan, Rajesh ^b  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Autologous salvaged blood; Cancer surgery; Circulating neoplastic cells; Intraoperative cell salvage; Metastatic cancer surgery; Metastatic spine tumour surgery

Indexed keywords

EID: 85066256685     PISSN: 25866583     EISSN: None     Source Type: Journal    
DOI: 10.14245/ns.1836140.070     Document Type: Review

References (91)

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.
2. International Agency for Research on Cancer and Cancer Research UK. World cancer factsheet. London: Cancer Research UK; 2012.
3. Witham TF, Khavkin YA, Gallia GL, et al. Surgery insight: current management of epidural spinal cord compression from metastatic spine disease. Nat Clin Pract Neurol 2006;2: 87-94.
4. Choi D, Crockard A, Bunger C, et al. Review of metastatic spine tumour classification and indications for surgery: the consensus statement of the Global Spine Tumour Study Group. Eur Spine J 2010;19:215-22.
5. Jacobs WB, Perrin RG. Evaluation and treatment of spinal metastases: an overview. Neurosurg Focus 2001;11:e10.
6. Kobayashi T, Miyakoshi N, Abe T, et al. Surgical intervention for vertebral metastases may benefit lung cancer patients no less than other patients: a retrospective study. J Med Case Rep 2017;11:4.
7. Sawhney M, Fletcher GG, Rice J, et al. Guidelines on management of pain in cancer and/or palliative care. Toronto (ON): Cancer Care Ontario; 2017 Sep 22. Program in Evidence-Based Care Evidence Summary No.: 18-4.
8. Zaw AS, Kantharajanna SB, Maharajan K, et al. Perioperative blood transfusion: does it influence survival and cancer progression in metastatic spine tumor surgery? Transfusion 2017;57:440-50.
9. Chen Y, Tai BC, Nayak D, et al. Blood loss in spinal tumour surgery and surgery for metastatic spinal disease: a meta-analysis. Bone Joint J 2013;95-B:683-8.
10. Kumar N, Zaw AS, Khine HE, et al. Blood loss and transfusion requirements in metastatic spinal tumor surgery: evaluation of influencing factors. Ann Surg Oncol 2016;23:2079-86.
11. Pennington Z, Ahmed AK, Molina CA, et al. Minimally invasive versus conventional spine surgery for vertebral metastases: a systematic review of the evidence. Ann Transl Med 2018;6:103.
12. Kumar N, Chen Y, Nath C, et al. What is the role of autologous blood transfusion in major spine surgery? Am J Orthop (Belle Mead NJ) 2012;41:E89-95.
13. Menitove JE. Transfusion related acute lung injury (TRALI): a review. Mo Med 2007;104:270-5.
14. Sarda P, Alshryda S. Topical usage of tranexamic acid: comparative analysis in patients with bilateral total knee replacement. EC Orthopaedics 2017;7:182-7.
15. Janssen SJ, Braun Y, Wood KB, et al. Allogeneic blood transfusions and postoperative infections after lumbar spine surgery. Spine J 2015;15:901-9.
16. Kato S, Chikuda H, Ohya J, et al. Risk of infectious complications associated with blood transfusion in elective spinal surgery-a propensity score matched analysis. Spine J 2016; 16:55-60.
17. Zaw AS, Kantharajanna SB, Maharajan K, et al. Metastatic spine tumor surgery: does perioperative blood transfusion influence postoperative complications? Transfusion 2017;57: 2790-8.
18. Spahn DR, Shander A, Hofmann A. The chiasm: transfusion practice versus patient blood management. Best Pract Res Clin Anaesthesiol 2013;27:37-42.
19. Carless PA, Henry DA, Moxey AJ, et al. Cell salvage for mini-mising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2010:CD001888.
20. Liang J, Shen J, Chua S, et al. Does intraoperative cell salvage system effectively decrease the need for allogeneic transfusions in scoliotic patients undergoing posterior spinal fusion? A prospective randomized study. Eur Spine J 2015;24:270-5.
21. Williamson KR, Taswell HF. Intraoperative blood salvage: a review. Transfusion 1991;31:662-75.
22. Davis RJ, Agnew DK, Shealy CR, et al. Erythrocyte viability in postoperative autotransfusion. J Pediatr Orthop 1993;13: 781-3.
23. Kumar N, Ahmed Q, Lee VK, et al. Are we ready for the use of intraoperative salvaged blood in metastatic spine tumour surgery? Eur Spine J 2016;25:3997-4007.
24. Kumar N, Chen Y, Zaw AS, et al. Use of intraoperative cell-salvage for autologous blood transfusions in metastatic spine tumour surgery: a systematic review. Lancet Oncol 2014;15: e33-41.
25. Catling S, Williams S, Freites O, et al. Use of a leucocyte filter to remove tumour cells from intra-operative cell salvage blood. Anaesthesia 2008;63:1332-8.
26. Waters JH, Yazer M, Chen YF, et al. Blood salvage and cancer surgery: a meta-analysis of available studies. Transfusion 2012;52:2167-73.
27. Wells PS. Safety and efficacy of methods for reducing perioperative allogeneic transfusion: a critical review of the literature. Am J Ther 2002;9:377-88.
28. Kumar N, Ahmed Q, Lee VK, et al. Can there be a place for intraoperative salvaged blood in spine tumor surgery? Ann Surg Oncol 2014;21:2436-43.
29. Kumar N, Lam R, Zaw AS, et al. Flow cytometric evaluation of the safety of intraoperative salvaged blood filtered with leucocyte depletion filter in spine tumour surgery. Ann Surg Oncol 2014;21:4330-5.
30. Kumar N, Zaw AS, Khoo BL, et al. Intraoperative cell salvage in metastatic spine tumour surgery reduces potential for re-infusion of viable cancer cells. Eur Spine J 2016;25:4008-15.
31. Autologous blood transfusions. Council on scientific affairs. JAMA 1986;256:2378-80.
32. Yaw PB, Sentany M, Link WJ, et al. Tumor cells carried through autotransfusion. Contraindication to intraoperative blood recovery? JAMA 1975;231:490-1.
33. Yamaguchi K, Takagi Y, Aoki S, et al. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann Surg 2000;232:58-65.
34. Allan AL, Keeney M. Circulating tumor cell analysis: technical and statistical considerations for application to the clinic. J Oncol 2010;2010:426218.
35. Dale RF, Kipling RM, Smith MF, et al. Separation of malignant cells during autotransfusion. Br J Surg 1988;75:581.
36. Lane TA. The effect of storage on the metastatic potential of tumor cells collected in autologous blood. An animal model. Transfusion 1989;29:418-20.
37. Hansen E, Wolff N, Knuechel R, et al. Tumor cells in blood shed from the surgical field. Arch Surg 1995;130:387-93.
38. Hart OJ 3rd, Klimberg IW, Wajsman Z, et al. Intraoperative autotransfusion in radical cystectomy for carcinoma of the bladder. Surg Gynecol Obstet 1989;168:302-6.
39. Klimberg IW. Autotransfusion and blood conservation in urologic oncology. Semin Surg Oncol 1989;5:286-92.
40. Bower MR, Ellis SF, Scoggins CR, et al. Phase II comparison study of intraoperative autotransfusion for major oncologic procedures. Ann Surg Oncol 2011;18:166-73.
41. Beck-Schimmer B, Romero B, Booy C, et al. Release of inflammatory mediators in irradiated cell salvage blood and their biological consequences in human beings following transfusion. Eur J Anaesthesiol 2004;21:46-52.
42. Connor JP, Morris PC, Alagoz T, et al. Intraoperative autologous blood collection and autotransfusion in the surgical management of early cancers of the uterine cervix. Obstet Gynecol 1995;86:373-8.
43. Foltys D, Zimmermann T, Heise M, et al. Liver transplantation for hepatocellular carcinoma: is there a risk of recurrence caused by intraoperative blood salvage autotransfusion? Eur Surg Res 2011;47:182-7.
44. Fujimoto J, Okamoto E, Yamanaka N, et al. Autotransfusion in hepatectomy for hepatocellular carcinoma. Nihon Geka Gakkai Zasshi 1991;92:825-30.
45. Martin RC, Wellhausen SR, Moehle DA, et al. Evaluation of intraoperative autotransfusion filtration for hepatectomy and pancreatectomy. Ann Surg Oncol 2005;12:1017-24.
46. Kim JM, Kim GS, Joh JW, et al. Long-term results for living donor liver transplant recipients with hepatocellular carcinoma using intraoperative blood salvage with leukocyte depletion filter. Transpl Int 2013;26:84-9.
47. Perseghin P, Viganò M, Rocco G, et al. Effectiveness of leukocyte filters in reducing tumor cell contamination after intraoperative blood salvage in lung cancer patients. Vox Sang 1997;72:221-4.
48. Davis M, Sofer M, Gomez-Marin O, et al. The use of cell salvage during radical retropubic prostatectomy: does it influence cancer recurrence? BJU Int 2003;91:474-6.
49. Ford BS, Sharma S, Rezaishiraz H, et al. Effect of perioperative blood transfusion on prostate cancer recurrence. Urol Oncol 2008;26:364-7.
50. Gray CL, Amling CL, Polston GR, et al. Intraoperative cell salvage in radical retropubic prostatectomy. Urology 2001; 58:740-5.
51. Nieder AM, Carmack AJ, Sved PD, et al. Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate. Urology 2005;65:730-4.
52. Nieder AM, Manoharan M, Yang Y, et al. Intraoperative cell salvage during radical cystectomy does not affect long-term survival. Urology 2007;69:881-4.
53. Poli M, Camargo A, Villa L, et al. Intraoperative autologous blood recovery in prostate cancer surgery: in vivo validation using a tumour marker. Vox Sang 2008;95:308-12.
54. Stoffel JT, Topjian L, Libertino JA. Analysis of peripheral blood for prostate cells after autologous transfusion given during radical prostatectomy. BJU Int 2005;96:313-5.
55. Gorin MA, Eldefrawy A, Manoharan M, et al. Oncologic outcomes following radical prostatectomy with intraoperative cell salvage. World J Urol 2012;30:379-83.
56. Zaw AS, Bangalore Kantharajanna S, Kumar N. Is autologous salvaged blood a viable option for patient blood management in oncologic surgery? Transfus Med Rev 2017;31: 56-61.
57. Allard WJ, Matera J, Miller MC, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004;10:6897-904.
58. Botteri E, Sandri MT, Bagnardi V, et al. Modeling the relationship between circulating tumour cells number and prognosis of metastatic breast cancer. Breast Cancer Res Treat 2010;122:211-7.
59. Moreno JG, Miller MC, Gross S, et al. Circulating tumor cells predict survival in patients with metastatic prostate cancer. Urology 2005;65:713-8.
60. Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004;351:781-91.
61. Danila DC, Heller G, Gignac GA, et al. Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res 2007;13:7053-8.
62. de Bono JS, Scher HI, Montgomery RB, et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 2008;14:6302-9.
63. Fidler IJ. Macrophages and metastasis: a biological approach to cancer therapy. Cancer Res 1985;45:4714-26.
64. Kumar N, Zaw AS, Kantharajanna SB, et al. Metastatic efficiency of tumour cells can be impaired by intraoperative cell salvage process: truth or conjecture? Transfus Med 2017;27 Suppl 5:327-34.
65. Terraube V, Marx I, Denis CV. Role of von Willebrand factor in tumor metastasis. Thromb Res 2007;120 Suppl 2:S64-70.
66. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002;2:563-72.
67. Karczewski DM, Lema MJ, Glaves D. The efficiency of an autotransfusion system for tumor cell removal from blood salvaged during cancer surgery. Anesth Analg 1994;78:1131-5.
68. Mirhashemi R, Averette HE, Deepika K, et al. The impact of intraoperative autologous blood transfusion during type III radical hysterectomy for early-stage cervical cancer. Am J Obstet Gynecol 1999;181:1310-5.
69. Hirano T, Yamanaka J, Iimuro Y, et al. Long-term safety of autotransfusion during hepatectomy for hepatocellular carcinoma. Surg Today 2005;35:1042-6.
70. Klimberg I, Sirois R, Wajsman Z, et al. Intraoperative autotransfusion in urologic oncology. Arch Surg 1986;121:1326-9.
71. Park KI, Kojima O, Tomoyoshi T. Intra-operative autotransfusion in radical cystectomy. Br J Urol 1997;79:717-21.
72. MacIvor D, Nelson J, Triulzi D. Impact of intraoperative red blood cell salvage on transfusion requirements and outcomes in radical prostatectomy. Transfusion 2009;49:1431-4.
73. Muscari F, Suc B, Vigouroux D, et al. Blood salvage autotransfusion during transplantationfor hepatocarcinoma: does it increase the risk of neoplastic recurrence? Transpl Int 2005;18:1236-9.
74. Vanderlinde ES, Heal JM, Blumberg N. Autologous transfusion. BMJ 2002;324:772-5.
75. Gharehbaghian A, Haque KM, Truman C, et al. Effect of autologous salvaged blood on postoperative natural killer cell precursor frequency. Lancet 2004;363:1025-30.
76. Islam N, Whitehouse M, Mehendale S, et al. Post-traumatic immunosuppression is reversed by anti-coagulated salvaged blood transfusion: deductions from studying immune status after knee arthroplasty. Clin Exp Immunol 2014;177:509-20.
77. Colwell CW Jr, Beutler E, West C, et al. Erythrocyte viability in blood salvaged during total joint arthroplasty with cement. J Bone Joint Surg Am 2002;84-A:23-5.
78. Salaria ON, Barodka VM, Hogue CW, et al. Impaired red blood cell deformability after transfusion of stored allogeneic blood but not autologous salvaged blood in cardiac surgery patients. Anesth Analg 2014;118:1179-87.
79. Bridgens JP, Evans CR, Dobson PM, et al. Intraoperative red blood-cell salvage in revision hip surgery. A case-matched study. J Bone Joint Surg Am 2007;89:270-5.
80. Krajewski K, Ashley RK, Pung N, et al. Successful blood conservation during craniosynostotic correction with dual therapy using procrit and cell saver. J Craniofac Surg 2008;19: 101-5.
81. Ashworth A, Klein AA. Cell salvage as part of a blood conservation strategy in anaesthesia. Br J Anaesth 2010;105:401-16.
82. Galaal K, Lopes A, Pritchard C, et al. Trial of intraoperative cell salvage versus transfusion in ovarian cancer (TIC TOC): protocol for a randomised controlled feasibility study. BMJ Open Forthcoming 2018.
83. Dzik WH, Sherburne B. Intraoperative blood salvage: medical controversies. Transfus Med Rev 1990;4:208-35.
84. Esper SA, Waters JH. Intra-operative cell salvage: a fresh look at the indications and contraindications. Blood Transfus 2011;9:139-47.
85. Waters JH. Intraoperative blood recovery. ASAIO J 2013;59: 11-7.
86. Kumar N, Tan JHJ, Ravikumar N, et al. Is salvaged autogen-ic blood transfusion safe in metastatic spine surgery: a preliminary report from a prospective clinical trial. Singapore: National University Hospital; 2018.
87. Han S, Kim G, Ko JS, et al. Safety of the use of blood salvage and autotransfusion during liver transplantation for hepatocellular carcinoma. Ann Surg 2016;264:339-43.
88. Araujo RL, Pantanali CA, Haddad L, et al. Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence? World J Gas-trointest Surg 2016;8:161-8.
89. Ubee S, Kumar M, Athmanathan N, et al. Intraoperative red blood cell salvage and autologous transfusion during open radical retropubic prostatectomy: a cost-benefit analysis. Ann R Coll Surg Engl 2011;93:157-61.
90. Raval JS, Nelson JB, Woldemichael E, et al. Intraoperative cell salvage in radical prostatectomy does not appear to increase long-term biochemical recurrence, metastases, or mortality. Transfusion 2012;52:2590-3.
91. Chalfin HJ, Frank SM, Feng Z, et al. Allogeneic versus autologous blood ransfusion and survival after radical prostatectomy. Transfusion 2014;54:2168-74.